Company’s 36-month beta value is 4.30.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for NXL is 10.44M, and currently, short sellers hold a 3.07% ratio of that floaft. The average trading volume of NXL on January 22, 2025 was 1.76M shares.
NXL) stock’s latest price update
Nexalin Technology Inc (NASDAQ: NXL) has seen a decline in its stock price by -10.76 in relation to its previous close of 3.16. However, the company has experienced a 12.35% gain in its stock price over the last five trading sessions. globenewswire.com reported 2024-12-23 that AI Components for Electronic Data Capture and Patient Monitoring to be Integrated into Phase 2 AI Components for Electronic Data Capture and Patient Monitoring to be Integrated into Phase 2
NXL’s Market Performance
NXL’s stock has risen by 12.35% in the past week, with a monthly drop of -18.97% and a quarterly rise of 113.64%. The volatility ratio for the week is 13.97% while the volatility levels for the last 30 days are 12.49% for Nexalin Technology Inc The simple moving average for the last 20 days is -2.88% for NXL stock, with a simple moving average of 54.48% for the last 200 days.
NXL Trading at -19.44% from the 50-Day Moving Average
After a stumble in the market that brought NXL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -37.19% of loss for the given period.
Volatility was left at 12.49%, however, over the last 30 days, the volatility rate increased by 13.97%, as shares sank -4.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.05% lower at present.
During the last 5 trading sessions, NXL rose by +12.35%, which changed the moving average for the period of 200-days by +17.50% in comparison to the 20-day moving average, which settled at $2.90. In addition, Nexalin Technology Inc saw 2.17% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NXL starting from Owens David, who purchase 500 shares at the price of $2.19 back on Oct 28 ’24. After this action, Owens David now owns 148,293 shares of Nexalin Technology Inc, valued at $1,095 using the latest closing price.
Owens David, the Chief Medical Officer of Nexalin Technology Inc, purchase 1,000 shares at $0.95 during a trade that took place back on Aug 13 ’24, which means that Owens David is holding 147,793 shares at $950 based on the most recent closing price.
Stock Fundamentals for NXL
Current profitability levels for the company are sitting at:
- -40.13 for the present operating margin
- -5.73 for the gross margin
The net margin for Nexalin Technology Inc stands at -34.27. The total capital return value is set at -1.31. Equity return is now at value -135.57, with -114.63 for asset returns.
Currently, EBITDA for the company is -5.69 million with net debt to EBITDA at 0.01. When we switch over and look at the enterprise to sales, we see a ratio of 223.28. The receivables turnover for the company is 10.68for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 16.39.
Conclusion
In a nutshell, Nexalin Technology Inc (NXL) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
